You are here

  • Home
  • Online First
  • MEK inhibition for low-grade serous ovarian cancer: are we there yet?

Article info

Article menu

other Versions

Download PDFPDF
Commentary
MEK inhibition for low-grade serous ovarian cancer: are we there yet?

Authors

  • Mariana Scaranti Hospital Sírio-Libanês, Sao Paulo, BrazilUniversidade de São Paulo, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Sao Paulo, SP, Brazil PubMed articlesGoogle scholar articles
  • Maria Cecília Mathias-Machado Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Sao Paulo, SP, Brazil PubMed articlesGoogle scholar articles
  • Christina Guo Royal Marsden NHS Foundation Trust, London, London, UKThe Institute of Cancer Research, London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mariana Scaranti, Hospital Sírio-Libanês, Sao Paulo, SP 01308-050, Brazil; scarantimariana{at}gmail.com

Citation

Scaranti M, Mathias-Machado MC, Guo C
MEK inhibition for low-grade serous ovarian cancer: are we there yet?
International Journal of Gynecologic Cancer Published Online First: 10 November 2020. doi: 10.1136/ijgc-2020-002122

Publication history

  • Received October 11, 2020
  • Accepted October 26, 2020
  • First published November 10, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.